Source:http://linkedlifedata.com/resource/pubmed/id/15808537
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-4-5
|
pubmed:abstractText |
Antibodies can mediate injury of organ transplants by several mechanisms, including complement activation and interaction with Fc receptors on cells. We tested the hypothesis that antibodies could also cause up-regulation of complement receptors on cells to increase the responses to complement activation by interaction with split products of C3. In our experimental model, B10.A (H-2(a)) cardiac transplants survive significantly longer in C57BL/6 (H-2(b)) immunoglobulin knockout recipients (IgKO) than in their wild-type counterparts. Passive transfer of specific antibodies to donor MHC class I to IgKO recipients of cardiac allografts at the time coinciding with a vigorous cellular infiltration reconstituted acute rejection. We tested the effects of alloantibodies on CR1/2 expression by alloantigen-stimulated T cells. Both CD4(+)/CR1/2(+) and CD8(+)/CR1/2(+) populations of T cells were expanded in C57BL/6 splenocytes stimulated by B10.A alloantigen in 7-day MLR after coculture with endothelial cells sensitized with IgG1 and IgG2b mAb specific to MHC. Endothelial cells sensitized with antibodies also caused an expansion of CD8(+) T cells expressing CR1/2 in lymph node lymphocytes harvested from a C57BL/6 recipient of a B10.A cardiac allograft. These data suggest that antibodies can augment the cellular rejection process through expanding the population of T cells interacting with complement split products.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15808537-Animals,
pubmed-meshheading:15808537-Cell Line,
pubmed-meshheading:15808537-Endothelium, Vascular,
pubmed-meshheading:15808537-Flow Cytometry,
pubmed-meshheading:15808537-Heart Transplantation,
pubmed-meshheading:15808537-Isoantigens,
pubmed-meshheading:15808537-Lymph Nodes,
pubmed-meshheading:15808537-Mice,
pubmed-meshheading:15808537-Mice, Inbred C3H,
pubmed-meshheading:15808537-Mice, Inbred C57BL,
pubmed-meshheading:15808537-Mice, Knockout,
pubmed-meshheading:15808537-Receptors, Complement 3b,
pubmed-meshheading:15808537-Receptors, Complement 3d,
pubmed-meshheading:15808537-T-Lymphocytes
|
pubmed:articleTitle |
Expression of CR1/2 receptor on alloantigen-stimulated mouse T cells.
|
pubmed:affiliation |
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|